Investing

Investment analysis, share recommendations, and market insights.

Premium

“HOT” stock: ResMed (RMD)

In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk explains why Morgans regards ResMed (RMD) as a BUY.

Maureen Jordan · February 2, 2026
Premium

Three more bargains!

Here are three more stocks that look to be good buying opportunities at current prices.

James Dunn · February 2, 2026
Premium

Two bargains

Here are two stocks that I consider bargains. They are in vastly different businesses – one more easily understandable than the other.

James Dunn · January 29, 2026
Premium

“HOT” stock: South32 (S32)

In our second “HOT” stock article today as Monday was Australia Day, Raymond Chan, Head of Asian Desk at Morgans, explains why the analysts have a BUY rating on South 32 (S32) and at what target price.

Maureen Jordan · January 29, 2026
Premium

“HOT” stock: FUEL

In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, says he’s been bullish on commodities for a few years now and explains that one way to capture this potential upside in energy is via the Betashares Global Energy ETF – FUEL.

Maureen Jordan · January 29, 2026
Premium

Three lithium picks

Lithium prices have been rising since mid-2025, but the surge of the white metal into 2026 has been remarkable. Here are three opportunities that might look appealing to some investors.

James Dunn · January 22, 2026

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.